Literature DB >> 22304720

Hemopressin forms self-assembled fibrillar nanostructures under physiologically relevant conditions.

Martha G Bomar1, Steven J Samuelsson, Patrick Kibler, Krishna Kodukula, Amit K Galande.   

Abstract

The nonapeptide hemopressin, which is derived from the α chain of hemoglobin, has been reported to exhibit inverse agonist activity against the CB1 receptor. Administration of this peptide in animal models led to decreased food intake and elicited hypotensive and antinociceptive effects. On the basis of hemopressin's potential in therapeutic applications and the lack of a structure-activity relationship study in literature, we aimed to determine the conformational features of hemopressin under physiological conditions. We conducted transmission electron microscopy experiments of hemopressin, revealing that it self-assembles into fibrils under aqueous conditions at pH 7.4. Circular dichroism and nuclear magnetic resonance experiments indicate that the peptide adopts a mostly extended β-like structure, which may contribute to its self-assembly and fibril formation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22304720     DOI: 10.1021/bm201836f

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  8 in total

Review 1.  Modulation of the cannabinoid receptors by hemopressin peptides.

Authors:  Martha G Bomar; Amit K Galande
Journal:  Life Sci       Date:  2012-08-01       Impact factor: 5.037

2.  Hemopressin, an inverse agonist of cannabinoid receptors, inhibits neuropathic pain in rats.

Authors:  Elaine F Toniolo; Estêfani T Maique; Wilson A Ferreira; Andrea S Heimann; Emer S Ferro; Dinah L Ramos-Ortolaza; Lydia Miller; Lakshmi A Devi; Camila S Dale
Journal:  Peptides       Date:  2014-04-03       Impact factor: 3.750

3.  Brain RVD-haemopressin, a haemoglobin-derived peptide, inhibits bombesin-induced central activation of adrenomedullary outflow in the rat.

Authors:  Kenjiro Tanaka; Takahiro Shimizu; Toshihiko Yanagita; Takayuki Nemoto; Kumiko Nakamura; Keisuke Taniuchi; Fotios Dimitriadis; Kunihiko Yokotani; Motoaki Saito
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

4.  Disordered Peptides Looking for Their Native Environment: Structural Basis of CB1 Endocannabinoid Receptor Binding to Pepcans.

Authors:  Alessandro Emendato; Remo Guerrini; Erika Marzola; Hans Wienk; Rolf Boelens; Serena Leone; Delia Picone
Journal:  Front Mol Biosci       Date:  2018-11-16

Review 5.  Intracellular Peptides in Cell Biology and Pharmacology.

Authors:  Christiane B de Araujo; Andrea S Heimann; Ricardo A Remer; Lilian C Russo; Alison Colquhoun; Fábio L Forti; Emer S Ferro
Journal:  Biomolecules       Date:  2019-04-16

Review 6.  New Insights Into Peptide Cannabinoids: Structure, Biosynthesis and Signaling.

Authors:  Agustín Riquelme-Sandoval; Caio O de Sá-Ferreira; Leo M Miyakoshi; Cecilia Hedin-Pereira
Journal:  Front Pharmacol       Date:  2020-12-09       Impact factor: 5.810

7.  How well does molecular simulation reproduce environment-specific conformations of the intrinsically disordered peptides PLP, TP2 and ONEG?

Authors:  Lauren M Reid; Ileana Guzzetti; Tor Svensson; Anna-Carin Carlsson; Wu Su; Tomas Leek; Lena von Sydow; Werngard Czechtizky; Marija Miljak; Chandra Verma; Leonardo De Maria; Jonathan W Essex
Journal:  Chem Sci       Date:  2022-01-20       Impact factor: 9.825

8.  Synthesis of hemopressin peptides by classical solution phase fragment condensation.

Authors:  P Anantha Reddy; Sean T Jones; Anita H Lewin; F Ivy Carroll
Journal:  Int J Pept       Date:  2012-11-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.